Pricing Log in Create free account

IGC Pharma, Inc. (IGC) vs Prima BioMed Ltd (IMMP)

IGC Pharma, Inc. and Prima BioMed Ltd are both Biotechnology companies. IGC Pharma, Inc. is the larger, with a market value of $26.3M against $23.7M — 1.1× the size. Across the 12 metrics below, Prima BioMed Ltd leads on 8 and IGC Pharma, Inc. on 4.

Valuation

Metric IGC IMMP Biotechnology median
P/E n/m n/m 8.50
P/S 22.78 n/m 9.71
P/B 4.09 0.05 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 23.44 n/m 9.21
Earnings yield (36.00%) (40.42%) (33.15%)
Free cash flow yield (22.67%) (1,275.20%) (25.50%)

Profitability

Metric IGC IMMP Biotechnology median
Gross margin 32.33% — 65.16%
Operating margin (912.44%) — 0.00%
Net margin (795.46%) — 0.00%
Free cash flow margin (516.53%) 0.00% 0.00%
Return on equity (143.46%) 0.00% (56.36%)
Return on assets (100.44%) 0.00% (48.04%)
Return on invested capital (91.53%) 0.00% 0.00%

Growth

Metric IGC IMMP Biotechnology median
Revenue growth (TTM) (13.38%) — 6.02%
EPS growth (last fiscal year) 57.85% (33.84%) 30.26%
Revenue growth, 5-year CAGR (20.77%) 40.79% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IGC IMMP Biotechnology median
Debt to equity 0.18 0.01 0.00
Current ratio 0.39 2.97 4.72
Net debt to EBITDA 0.04 0.92 0.96

Dividend

Metric IGC IMMP Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric IGC IMMP Biotechnology median
Market cap 26.27m 23.66m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack